Jillian B. Thomsen - Net Worth and Insider Trading
Jillian B. Thomsen Net Worth
The estimated net worth of Jillian B. Thomsen is at least $413,816 dollars as of 2024-11-13. Jillian B. Thomsen is the CFO of Nektar Therapeutics and owns about 313,497 shares of Nektar Therapeutics (NKTR) stock worth over $413,816. Details can be seen in Jillian B. Thomsen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jillian B. Thomsen has not made any transactions after 2023-02-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jillian B. Thomsen
Jillian B. Thomsen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jillian B. Thomsen owns 1 companies in total, including Nektar Therapeutics (NKTR) .
Click here to see the complete history of Jillian B. Thomsen’s form 4 insider trades.
Insider Ownership Summary of Jillian B. Thomsen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2023-02-16 | VP & Chief Accounting Officer |
Jillian B. Thomsen Latest Holdings Summary
Jillian B. Thomsen currently owns a total of 1 stock. Jillian B. Thomsen owns 313,497 shares of Nektar Therapeutics (NKTR) as of February 16, 2023, with a value of $413,816.
Latest Holdings of Jillian B. Thomsen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2023-02-16 | 313,497 | 1.32 | 413,816 |
Holding Weightings of Jillian B. Thomsen
Jillian B. Thomsen Form 4 Trading Tracker
According to the SEC Form 4 filings, Jillian B. Thomsen has made a total of 16 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Nektar Therapeutics is the sale of 10,267 shares on February 16, 2023, which brought Jillian B. Thomsen around $30,801.
Insider Trading History of Jillian B. Thomsen
- 1
Jillian B. Thomsen Trading Performance
Jillian B. Thomsen Ownership Network
Ownership Network List of Jillian B. Thomsen
Ownership Network Relation of Jillian B. Thomsen
Jillian B. Thomsen Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Jillian B. Thomsen is the VP & Chief Accounting Officer of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Jillian B. Thomsen made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 111,800 shares made by Howard W Robin , a net sale of 52,375 shares made by Jonathan Zalevsky , and a net sale of 41,460 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 27,398 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 27,398 shares. During the past 18 months, 289,853 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 289,853 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Jillian B. Thomsen Mailing Address
Above is the net worth, insider trading, and ownership report for Jillian B. Thomsen. You might contact Jillian B. Thomsen via mailing address: C/o Nektar Therapeutics, 201 Industrial Road, San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
